Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

Investing

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

587 Articles

Paul Ausick | Sep 2, 2016 at 4:04 PM EDT

Bristol-Myers, Verifone Dive into Friday’s 52-Week Low Club

September 2, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in…

Chris Lange | Aug 25, 2016 at 8:45 AM EDT

Major Pharma Short Interest Faces Significant Drop

The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Aug 10, 2016 at 9:05 AM EDT

Major Pharma Short Interest Slides

The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Jon C. Ogg | Aug 8, 2016 at 12:45 PM EDT

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Credit Suisse sees the Bristol-Myers Squibb gap with Merck getting even worse, even though it still has robust I-O franchise…

Jon C. Ogg | Aug 8, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto, 21st Century Fox and More

The top analyst upgrades, downgrades and initiations seen on Monday morning include BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto and Twenty-First…

Chris Lange | Aug 5, 2016 at 10:35 AM EDT

Why Bristol-Myers Failure Is a Huge Win for Merck

Bristol-Myers Squibb shares took a nosedive early Friday's following an update in its late-stage Checkmate trial. But Bristol-Myer's failure was…

Chris Lange | Jul 28, 2016 at 9:45 AM EDT

Bristol-Myers Earnings Don’t Appear to Be Enough for Investors

Bristol-Myers Squibb released a better-than-expected second-quarter earnings report before the markets opened on Thursday.

Chris Lange | Jul 27, 2016 at 8:25 AM EDT

Short Sellers Get Selective on Major Pharma

The short interest data have been released for the July 15 settlement date. For the selected pharmaceutical stocks, short interest…

Lee Jackson | Jul 26, 2016 at 8:35 AM EDT

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

SunTrust Robinson Humphrey feels that the major pharmaceutical companies will outperform the rest of the year, and they cite new…

Chris Lange | Jul 13, 2016 at 9:15 AM EDT

Short Sellers Run for Cover From Major Pharma

The June 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Chris Lange | Jul 3, 2016 at 7:38 AM EDT

How Major Pharma Is Faring After the Brexit

The broad markets are recovering in the wake of the Brexit and it really appears to be one big head…

Chris Lange | Jun 27, 2016 at 8:11 AM EDT

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a…

Chris Lange | Jun 10, 2016 at 8:05 AM EDT

Major Pharma Has Short Sellers on the Run

The May 31 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Chris Lange | Jun 6, 2016 at 1:40 PM EDT

How Credit Suisse Views Major Pharma After ASCO

The ASCO annual meeting is absolutely making waves in the pharmaceutical industry. As a result, analysts are giving their two…

Chris Lange | Jun 2, 2016 at 10:50 AM EDT

Merrill Lynch Picks ASCO Winners

Merrill Lynch is one of the major firms that will be in attendance at the American Society of Clinical Oncology…

1 … 22 23 24 25 26 … 40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Bristol-Myers, Verifone Dive into Friday’s 52-Week Low Club

Major Pharma Short Interest Faces Significant Drop

Major Pharma Short Interest Slides

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Top Analyst Upgrades and Downgrades: BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto, 21st Century Fox and More

Why Bristol-Myers Failure Is a Huge Win for Merck

Bristol-Myers Earnings Don’t Appear to Be Enough for Investors

Short Sellers Get Selective on Major Pharma

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

Short Sellers Run for Cover From Major Pharma

How Major Pharma Is Faring After the Brexit

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

Major Pharma Has Short Sellers on the Run

How Credit Suisse Views Major Pharma After ASCO

Merrill Lynch Picks ASCO Winners

Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

3 Dividend Stocks Built for Retirement to Buy in June

From PC Maker to AI Giant: How Dell Rewarded Patient Investors With Nearly 1,900% Gains and AI Capex Determines The Future

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

3 Dividend Stocks Built for Retirement to Buy in June

From PC Maker to AI Giant: How Dell Rewarded Patient Investors With Nearly 1,900% Gains and AI Capex Determines The Future

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Bristol-Myers, Verifone Dive into Friday’s 52-Week Low Club

Major Pharma Short Interest Faces Significant Drop

Major Pharma Short Interest Slides

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Top Analyst Upgrades and Downgrades: BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto, 21st Century Fox and More

Why Bristol-Myers Failure Is a Huge Win for Merck

Bristol-Myers Earnings Don’t Appear to Be Enough for Investors

Short Sellers Get Selective on Major Pharma

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

Short Sellers Run for Cover From Major Pharma

How Major Pharma Is Faring After the Brexit

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

Major Pharma Has Short Sellers on the Run

How Credit Suisse Views Major Pharma After ASCO

Merrill Lynch Picks ASCO Winners

Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

3 Dividend Stocks Built for Retirement to Buy in June

From PC Maker to AI Giant: How Dell Rewarded Patient Investors With Nearly 1,900% Gains and AI Capex Determines The Future

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation